微针介导的纳米递送系统在经皮给药中的研究进展

    Research Progress of Microneedle-mediated Nanodelivery Systems in Transdermal Drug Delivery

    • 摘要: 由于角质层的屏障作用,大多数药物的经皮渗透效率较低,导致经皮给药系统的应用受到很大的限制。微针(microneedle,MNs)递药系统和纳米递药系统是目前透皮给药研究最为广泛的2种给药系统。MNs递药系统能在皮肤表面形成微小通道以促进药物的渗透,能快速将纳米药物送至毛细血管参与全身循环,且不触及真皮层中的神经产生痛感;纳米递药系统既能增加药物渗透,还可改善药物的药动学和药效学特征,提高生物利用度,并减轻不良反应。因此,MNs介导的纳米递送系统作为一种经皮给药的新兴载体显示出了巨大的应用潜力与前景,受到了越来越广泛的关注。

       

      Abstract: Due to the effect of cuticle barrier, the transdermal penetration efficiency of most drugs is low. Therefore, the application of transdermal drug delivery system is greatly limited. Microneedle drug delivery system and nanodelivery system are the two most widely studied transdermal drug delivery systems. The microneedle drug delivery system can form tiny channels on the surface of the skin to promote drug penetration, and can quickly send nanodrugs to the capillaries to participate in the systemic circulation without touching the nerves in the dermis to cause pain. The nanodelivery system not only enhances drug penetration, but also improves the pharmacokinetic and pharmacodynamic properties of drugs, thereby increasing bioavailability, while minimizing adverse reactions. As a novel transdermal drug delivery carrier, microneedle-mediated nanodelivery system has shown great potential and promising prospect, attracting widespread attention in recent research.

       

    /

    返回文章
    返回